Window Therapeutics
Year
2021
Area
Healthcare and Medical
![](https://deshpande.mit.edu/wp-content/uploads/2022/01/Window-Therepeutics-aspect-ratio-580-360-580x360-c-default.jpg)
Window Therapeutics is developing cancer therapies designed to work against diseased cells and not healthy ones.
It draws on its proprietary Bottle-brush-Analogue-Macromonomer (BAM) technology to open the therapeutic windows of a wide range of drug classes, offering clinicians and patients more numerous and effective treatment regimens.
![](https://live-mit-deshpande.pantheonsite.io/wp-content/uploads/2021/12/iStock-1011146302-small.jpg)
A novel prodrug platform as the next generation blood cancer therapy
The company is a spinout from the 2018 project, A novel prodrug platform as the next generation blood cancer therapy.
![](https://deshpande.mit.edu/wp-content/uploads/2021/12/MIT-Drug-Combinations-01-press_0.jpg)